# Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects

> **NCT02791815** · PHASE1 · COMPLETED · sponsor: **Actelion** · enrollment: 20 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Midazolam
- **DRUG:** Selexipag

## Key facts

- **NCT ID:** NCT02791815
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02791815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02791815, "Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02791815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*